Open Access Open Access  Restricted Access Subscription or Fee Access


DSVGK Kaladhar, Akhilesh Tiwari, Shristi Sharma


Peptic ulcers are also called as or duodenal ulcers or gastric ulcers that are open sores generally develop in the lining of the stomach due to food and climatic factors. H. pylori infections are potentially the most dangerous and are linked to several diseases like diabetes, cancer, cardiovascular diseases, etc. In the present study, in silico screening and evaluation of some metabolites from Momordica charantia like Momorcharin, Momordicin, Metformin, Pioglitazone, Glipizide, Gliclazide and Glibenclamide in the treatment of peptic ulcers has been conducted. Vacuolating cytotoxin autotransporter (VacA) causes ulceration and gastric lesions is interacting with Urease subunit alpha (ure a), Outer membrane protein-adhesin(babA), Acid-activated urea channel (ureI; rapidly enhances the production of ammonia) and Cytotoxicity-associated immunodominant antigen (CagA). CagA is directly interacting with Serine/threonine-protein kinase CtkA and Cag island protein (virD4). Glibenclamide, Glipizide and Momorcharin has shown good results with Vac A and CagA involved in peptic ulcer. The present study has shown that Glibenclamide is found as effective molecule in the control of peptic ulcer.


Peptic ulcers. Cag A, Vac A, in silico screening, Momordica charantia

Full Text:



Abdel-Rahman, R. F., Soliman, G. A., Saeedan, A. S., Ogaly, H. A., Abd-Elsalam, R. M., Alqasoumi, S. I., & Abdel-Kader, M. S. (2019). Molecular and biochemical monitoring of the possible herb-drug interaction between Momordica charantia extract and glibenclamide in diabetic rats. Saudi Pharmaceutical Journal, 27(6), 803-816.

Behera, T. K., Singh, A. K., & Staub, J. E. (2008). Comparative analysis of genetic diversity in Indian bitter gourd (Momordica charantia L.) using RAPD and ISSR markers for developing crop improvement strategies. Scientia Horticulturae, 115(3), 209-217.

De Luis, D. A., De La Calle, H., Roy, G., De Argila, C. M., Valdezate, S., Canton, R., & Boixeda, D. (1998). Helicobacter pylori infection and insulin-dependent diabetes mellitus. Diabetes research and clinical practice, 39(2), 143-146.

Fan, M., Kim, E. K., Choi, Y. J., Tang, Y., & Moon, S. H. (2019). The role of Momordica charantia in resisting obesity. International journal of environmental research and public health, 16(18), 3251.

Grover, J. K., & Yadav, S. P. (2004). Pharmacological actions and potential uses of Momordica charantia: a review. Journal of ethnopharmacology, 93(1), 123-132.

Gürbüz, I., Akyüz, Ç., Yeşilada, E., & Şener, B. (2000). Anti-ulcerogenic effect of Momordica charantia L. fruits on various ulcer models in rats. Journal of Ethnopharmacology, 71(1-2), 77-82.

Gürsan, N. (2005). Effects of Momordica charantia L.(Cucurbitaceae) on indomethacin-induced ulcer model in rats. The Turkish journal of gastroenterology: the official journal of Turkish Society of Gastroenterology, 16(2), 85-88.

Jan, B., Shams, R., Dar, A. H., Singh, A., & Khan, S. A. (2020). Bitter Gourd. In Antioxidants in Vegetables and Nuts-Properties and Health Benefits (pp. 175-189). Springer, Singapore.

Kim, J. M., Kim, J. S., Jung, H. C., Song, I. S., & Kim, C. Y. (2000). Virulence factors of Helicobacter pylori in Korean isolates do not influence proinflammatory cytokine gene expression and apoptosis in human gastric epithelial cells, nor do these factors influence the clinical outcome. Journal of gastroenterology, 35(12), 898-906.

Kumar, K. S., & Bhowmik, D. (2010). Traditional medicinal uses and therapeutic benefits of Momordica charantia Linn. International Journal of Pharmaceutical Sciences Review and Research, 4(3), 23-28.

Mattar, R., Marques, S. B., do Socorro Monteiro, M., Dos Santos, A. F., Iriya, K., & Carrilho, F. J. (2007). Helicobacter pylori cag pathogenicity island genes: clinical relevance for peptic ulcer disease development in Brazil. Journal of medical microbiology, 56(1), 9-14.

Nejati, S., Karkhah, A., Darvish, H., Validi, M., Ebrahimpour, S., & Nouri, H. R. (2018). Influence of Helicobacter pylori virulence factors CagA and VacA on pathogenesis of gastrointestinal disorders. Microbial pathogenesis, 117, 43-48.

Paul, A., & Raychaudhuri, S. S. (2010). Medicinal uses and molecular identification of two Momordica charantia varieties-a review. Electronic Journal of Biology, 6(2), 43-51.

Poovitha, S., & Parani, M. (2016). In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.). BMC complementary and alternative medicine, 16(1), 1-8.

Rezaeizadeh, A. L. I. R. E. Z. A. (2013). Some Mechanisms for Wound Healing Enhancing Effects of Bitter Gourd (Momordica charantia L.) Extract in Diabetic Rats (Doctoral dissertation, Ph. D. Thesis, Universiti Putra Malaysia, Serdang, Malaysia).

Singh, J., Cumming, E., Manoharan, G., Kalasz, H., & Adeghate, E. (2011). Suppl 2: Medicinal chemistry of the anti-diabetic effects of Momordica charantia: active constituents and modes of actions. The open medicinal chemistry journal, 5, 70.

Singh, V., Mahaur, S., & Kushwaha, S. K. (2018). Nutraceuticals: A new golden era in health and disease. Asian Journal of Research in Chemistry, 11(3), 652-658.

Thiagarajan, S. K., Rama Krishnan, K., Ei, T., Husna Shafie, N., Arapoc, D. J., & Bahari, H. (2019). Evaluation of the effect of aqueous Momordica charantia Linn. extract on zebrafish embryo model through acute toxicity assay assessment. Evidence-Based Complementary and Alternative Medicine, 2019.

Xiang, Z., Censini, S., Bayeli, P. F., Telford, J. L., Figura, N., Rappuoli, R., & Covacci, A. (1995). Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infection and immunity, 63(1), 94-98.

Yan, J. K., Wu, L. X., Qiao, Z. R., Cai, W. D., & Ma, H. (2019). Effect of different drying methods on the product quality and bioactive polysaccharides of bitter gourd (Momordica charantia L.) slices. Food chemistry, 271, 588-596.


  • There are currently no refbacks.